← All trials
NCT02138331
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2014
- Primary completion
- Jul 1, 2014
- Completion date
- Sep 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- General Committee of Teaching Hospitals and Institutes, EgyptLead sponsor
- Cairo UniversityStudy director
- Sahel General HospitalOverall official - principal investigator
- Sahel General HospitalStudy chair
- General Committee of Teaching Hospitals and Institutes, EgyptReponsible party - principal investigator
- Cairo UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.